These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 2969768

  • 1. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O, Roncada P, Dall'Olio R, Montanaro N.
    Brain Res; 1988 Jul 12; 455(2):390-3. PubMed ID: 2969768
    [Abstract] [Full Text] [Related]

  • 2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 12; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 12; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 4. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 5. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec 10; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 6. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 10; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 7. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Feb 10; 20(2):589-97. PubMed ID: 2953990
    [Abstract] [Full Text] [Related]

  • 8. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 10; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 9. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 10; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 10. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM, Cereska KS.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr 10; 339(4):383-6. PubMed ID: 2567965
    [Abstract] [Full Text] [Related]

  • 11. Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats.
    Criswell H, Mueller RA, Breese GR.
    J Neurosci; 1989 Jan 10; 9(1):125-33. PubMed ID: 2521511
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.
    Winkler JD, Thermos K, Weiss B.
    Psychopharmacology (Berl); 1987 Jan 10; 92(3):285-91. PubMed ID: 2957717
    [Abstract] [Full Text] [Related]

  • 13. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 14. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C, Bédard PJ, Rioux L, Gaudin D, Martinoli MG, Pelletier G, Di Paolo T.
    Brain Res; 1991 Sep 06; 558(2):251-63. PubMed ID: 1838295
    [Abstract] [Full Text] [Related]

  • 15. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
    Gandolfi O, Dall'olio R, Vaccheri A, Roncada P, Montanaro N.
    Pharmacol Biochem Behav; 1988 Jun 06; 30(2):463-9. PubMed ID: 3262877
    [Abstract] [Full Text] [Related]

  • 16. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul 06; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 17. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
    Arnt J, Hyttel J.
    Psychopharmacology (Berl); 1985 Jul 06; 85(3):346-52. PubMed ID: 2860689
    [Abstract] [Full Text] [Related]

  • 18. Induction of oral dyskinesias in naive rats by D1 stimulation.
    Rosengarten H, Schweitzer JW, Friedhoff AJ.
    Life Sci; 1983 Dec 19; 33(25):2479-82. PubMed ID: 6227782
    [Abstract] [Full Text] [Related]

  • 19. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J.
    Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283
    [Abstract] [Full Text] [Related]

  • 20. Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
    Rosengarten H, Schweitzer JW, Egawa M, Friedhoff AJ.
    Adv Exp Med Biol; 1988 Jul 11; 235():159-67. PubMed ID: 2976249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.